Sabra Health Care REIT (NASDAQ:SBRA) had its price target lowered by investment analysts at Wells Fargo from $24.00 to $19.00 in a research note issued on Tuesday, MarketBeat reports. The brokerage presently has a “market perform” rating on the real estate investment trust’s stock. Wells Fargo’s price target indicates a potential upside of 9.13% from the stock’s current price. The analysts noted that the move was a valuation call.

Several other equities research analysts have also weighed in on SBRA. Zacks Investment Research lowered Sabra Health Care REIT from a “hold” rating to a “sell” rating in a research note on Wednesday, January 10th. BidaskClub upgraded Sabra Health Care REIT from a “strong sell” rating to a “sell” rating in a research note on Thursday, March 8th. Mizuho upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and set a $24.00 price target on the stock in a research report on Wednesday, March 14th. ValuEngine lowered Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Finally, Stifel Nicolaus restated a “hold” rating and set a $21.00 price target (down from $22.00) on shares of Sabra Health Care REIT in a research report on Thursday, February 22nd. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $23.64.

How to Become a New Pot Stock Millionaire

Shares of Sabra Health Care REIT (NASDAQ SBRA) opened at $17.41 on Tuesday. Sabra Health Care REIT has a 12 month low of $15.77 and a 12 month high of $29.10. The firm has a market capitalization of $3,181.87, a P/E ratio of 14.51, a PEG ratio of 2.41 and a beta of 0.75. The company has a quick ratio of 6.85, a current ratio of 6.85 and a debt-to-equity ratio of 0.99.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, February 21st. The real estate investment trust reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.27. Sabra Health Care REIT had a return on equity of 7.19% and a net margin of 39.04%. The company had revenue of $166.47 million for the quarter, compared to analyst estimates of $158.82 million. sell-side analysts predict that Sabra Health Care REIT will post 2.5 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. California Public Employees Retirement System lifted its holdings in Sabra Health Care REIT by 178.8% during the 3rd quarter. California Public Employees Retirement System now owns 337,869 shares of the real estate investment trust’s stock worth $7,413,000 after buying an additional 216,669 shares in the last quarter. California State Teachers Retirement System lifted its holdings in Sabra Health Care REIT by 145.3% during the 3rd quarter. California State Teachers Retirement System now owns 280,303 shares of the real estate investment trust’s stock worth $6,150,000 after buying an additional 166,039 shares in the last quarter. Highbridge Capital Management LLC lifted its holdings in Sabra Health Care REIT by 12.1% during the 3rd quarter. Highbridge Capital Management LLC now owns 369,634 shares of the real estate investment trust’s stock worth $8,110,000 after buying an additional 39,954 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in Sabra Health Care REIT by 115.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,326,601 shares of the real estate investment trust’s stock worth $29,105,000 after buying an additional 709,983 shares in the last quarter. Finally, Russell Investments Group Ltd. lifted its holdings in Sabra Health Care REIT by 22.2% during the 3rd quarter. Russell Investments Group Ltd. now owns 58,433 shares of the real estate investment trust’s stock worth $1,271,000 after buying an additional 10,601 shares in the last quarter. Institutional investors and hedge funds own 88.88% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Sabra Health Care REIT (SBRA) PT Lowered to $19.00 at Wells Fargo” was posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.watchlistnews.com/sabra-health-care-reit-sbra-pt-lowered-to-19-00-at-wells-fargo/1955402.html.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.